Showing 1 - 12 results of 12 for search 'Narjes Nasiri-Ansari', query time: 0.04s Refine Results
  1. 1
    Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances

    Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances by Narjes Nasiri-Ansari, Eva Kassi

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Perspectives and Challenges of COVID-19 with Obesity-Related Cancers

    Perspectives and Challenges of COVID-19 with Obesity-Related Cancers by Maria Dalamaga, Narjes Nasiri-Ansari, Nikolaos Spyrou

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges

    Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges by Dimitrios Tsilingiris, Narjes Nasiri-Ansari, Nikolaos Spyrou, Faidon Magkos, Maria Dalamaga

    Published 2022-05-01
    Get full text
    Article
  4. 4
    Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response

    Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response by Maria Eleftheria Evangelopoulos, Narjes Nasiri-Ansari, Eva Kassi, Anna Papadopoulou, Dimitrios Stergios Evangelopoulos, Paraskevi Moutsatsou

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response

    Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical resp... by Maria Eleftheria Evangelopoulos, Narjes Nasiri‑Ansari, Eva Kassi, Anna Papadopoulou, Dimitrios Stergios Evangelopoulos, Paraskevi Moutsatsou

    Published 2021-11-01
    Get full text
    Article
  6. 6
    SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection

    SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection by Theodoros Androutsakos, Narjes Nasiri-Ansari, Athanasios-Dimitrios Bakasis, Ioannis Kyrou, Efstathios Efstathopoulos, Harpal S. Randeva, Eva Kassi

    Published 2022-03-01
    Get full text
    Article
  7. 7
    Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review

    Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review by Narjes Nasiri-Ansari, Theodoros Androutsakos, Christina-Maria Flessa, Ioannis Kyrou, Gerasimos Siasos, Harpal S. Randeva, Eva Kassi, Athanasios G. Papavassiliou

    Published 2022-08-01
    Get full text
    Article
  8. 8
    Structural Speciation of Ti(IV)-(α-Hydroxycarboxylic Acid) Complexes in Metabolism-Related (Patho)Physiology—In Vitro Approaches to (Pre)Adipocyte Differentiation and Mineralization

    Structural Speciation of Ti(IV)-(α-Hydroxycarboxylic Acid) Complexes in Metabolism-Related (Patho)Physiology—In Vitro Approaches to (Pre)Adipocyte Differentiation and Mineralizatio... by Olga Tsave, Catherine Iordanidou, Antonios Hatzidimitriou, Maria P. Yavropoulou, Eva N. Kassi, Narjes Nasiri-Ansari, Catherine Gabriel, Athanasios Salifoglou

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research

    Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research by Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva

    Published 2022-12-01
    Get full text
    Article
  10. 10
    Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability

    Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability by Narjes Nasiri-Ansari, Eliana Spilioti, Ioannis Kyrou, Vassiliki Kalotychou, Antonios Chatzigeorgiou, Despina Sanoudou, Karin Dahlman-Wright, Harpal S. Randeva, Athanasios G. Papavassiliou, Paraskevi Moutsatsou, Eva Kassi

    Published 2022-09-01
    Get full text
    Article
  11. 11
    Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia

    Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia by Angeliki Valatsou, Panagiotis Theofilis, Spyridon Simantiris, Georgia Vogiatzi, Alexandros Briasoulis, Marios Sagris, Evangelos Oikonomou, Alexios S. Antonopoulos, Alkistis Pantopoulou, Narjes Nasiri-Ansari, Elizabeth Fragopoulou, Despoina Perrea, Konstantinos Tsioufis, Dimitris Tousoulis

    Published 2022-09-01
    Get full text
    Article
  12. 12
    Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE<sup>(-/-)</sup> Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

    Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE<sup>(-/-)</sup> Mice by Activating Autophagy and Reducing ER Stress and Apoptosis by Narjes Nasiri-Ansari, Chrysa Nikolopoulou, Katerina Papoutsi, Ioannis Kyrou, Christos S. Mantzoros, Georgios Kyriakopoulos, Antonios Chatzigeorgiou, Vassiliki Kalotychou, Manpal S. Randeva, Kamaljit Chatha, Konstantinos Kontzoglou, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi

    Published 2021-01-01
    Get full text
    Article

Search Tools: